EyePoint Pharmaceuticals Market Cap

EyePoint Pharmaceuticals has a market cap or net worth of $447.08 million as of April 22, 2025. Its market cap has decreased by -55.47% in one year.

Market Cap

447.08M

Enterprise Value

99.27M

1-Year Change

-55.47%

Ranking

#2957

Market Cap Chart

Since January 27, 2005, EyePoint Pharmaceuticals's market cap has increased from $388.60M to $447.08M, an increase of 15.05%. That is a compound annual growth rate of 0.69%.

Market Cap History

Date	Market Cap	% Change
Apr 21, 2025	405.50M	-20.26%
Dec 31, 2024	508.50M	-37.68%
Dec 29, 2023	816.00M	583.99%
Dec 30, 2022	119.30M	-66.13%
Dec 31, 2021	352.20M	273.09%
Dec 31, 2020	94.40M	-43.68%
Dec 31, 2019	167.60M	-6.53%
Dec 31, 2018	179.30M	266.67%
Dec 29, 2017	48.90M	-16.27%
Dec 30, 2016	58.40M	-58.82%
Dec 31, 2015	141.80M	17.58%
Dec 31, 2014	120.60M	12.71%
Dec 31, 2013	107.00M	279.43%
Dec 31, 2012	28.20M	22.08%
Dec 30, 2011	23.10M	-75.61%
Dec 31, 2010	94.70M	44.14%
Dec 31, 2009	65.70M	281.98%
Dec 31, 2008	17.20M	-70.19%
Dec 31, 2007	57.70M	-25.93%
Dec 29, 2006	77.90M	-62.73%
Dec 30, 2005	209.00M	-46.22%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	739.94B
UnitedHealth Group	391.48B
Johnson & Johnson	379.60B
AbbVie	302.50B
Novo Nordisk	284.50B
Abbott Laboratories	225.93B
Novartis AG	209.93B
AstraZeneca	208.11B

Market Cap Rankings